Paradoxical sleep deprivation modulates tyrosine hydroxylase expression in the nigrostriatal pathway and attenuates motor deficits induced by dopaminergic depletion

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 4, 2012, Pages 359-368

  Lima, Marcelo M S ^a   Andersen, Monica L ^b   Reksidler, Angela B ^a   Ferraz, Anete C ^a   Vital, Maria A B F ^a   Tufik, Sergio ^b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dopamine; Paradoxical sleep deprivation; Parkinson's disease; Reserpine; Rotenone; methyl p tyrosine

Indexed keywords

CATECHOLAMINE; METIROSINE; RESERPINE; ROTENONE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALEPSY; CELL DENSITY; CELL LOSS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OPEN FIELD TEST; PARADOXICAL SLEEP DEPRIVATION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SLEEP DEPRIVATION; SUBSTANTIA NIGRA PARS COMPACTA;

EID: 84862524853     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712800792839     Document Type: Article

References (51)

1. Steriade, M.; McCarley, R.W. Brainstem Control of Wakefulness and Sleep. Plenum, New York, 1990.
2. Monti, J.M. Involvement of histamine in the control of the waking state. Life Sci., 1993, 53(17), 1331-1338.
3. Lin, J.S.; Hou, Y.; Sakai, K.; Jouvet, M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J. Neurosci., 1996, 16(4), 1523-1537.
4. Steininger, T.L.; Alam, M.N.; Gong, H.; Szymusiak, R.; McGinty, D. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res., 1999, 840(1-2), 138-147.
5. Chemelli, R.M.; Willie, J.T.; Sinton, C.M.; Elmquist, J.K.; Scammell, T.; Lee, C.; Richardson, J.A.; Williams, S.C.; Xiong, Y.; Kisanuki, Y.; Fitch, T.E.; Nakazato, M.; Hammer, R.E.; Saper, C.B.; Yanagisawa, M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 1999, 98(4), 437-451.
6. Hagan, J.J.; Leslie, R.A.; Patel, S.; Evans, M.L.; Wattam, T.A.; Holmes, S.; Benham, C.D.; Taylor, S.G.; Routledge, C.; Hemmati, P.; Munton, R.P.; Ashmeade, T.E.; Shah, A.S.; Hatcher, J.P.; Hatcher, P.D.; Jones, D.N.; Smith, M.I.; Piper, D.C.; Hunter, A.J.; Porter, R.A.; Upton, N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA, 1999, 96(19), 10911-10916.
7. Lin, L.; Faraco, J.; Li, R.; Kadotani, H.; Rogers, W.; Lin, X.; Qiu, X.; de Jong, P.J.; Nishino, S.; Mignot, E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 1999, 98(3), 365-376.
8. Porkka-Heiskanen, T.; Strecker, R.E.; Thakkar, M.; Bjorkum, A.A.; Greene, R.W.; McCarley, R.W. Adenosine: a mediator of the sleepinducing effects of prolonged wakefulness. Science, 1997, 276(5316), 1265-1268.
9. Portas, C.M.; Thakkar, M.; Rainnie, D.G.; Greene, R.W.; McCarley, R.W. Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat. Neuroscience, 1997, 79(1), 225-235.
10. Wisor, J.P.; Nishino, S.; Sora, I.; Uhl, G.H.; Mignot, E.; Edgar, D.M. Dopaminergic role in stimulant-induced wakefulness. J. Neurosci., 2001, 21(5), 1787-1794.
11. Lena, I.; Parrot, S.; Deschaux, O.; Muffat-Joly, S.; Sauvinet, V.; Renaud, B.; Suaud-Chagny, M.F.; Gottesmann, C. Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep--wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J. Neurosci. Res., 2005, 81(6), 891-899.
12. Dzirasa, K.; Ribeiro, S.; Costa, R.; Santos, L.M.; Lin, S.C.; Grosmark, A.; Sotnikova, T.D.; Gainetdinov, R.R.; Caron, M.G.; Nicolelis, M.A. Dopaminergic control of sleep-wake states. J. Neurosci., 2006, 26(41), 10577-10589.
13. Lima, M.M.S.; Ersen, M.L.; Reksidler, A.B.; Vital, M.A.B.F.; Tufik, S. The role of the substantia nigra pars compacta in regulating sleep patterns in rats. PLoS One, 2007, 2, e513.
14. Marsden, C.A. Dopamine: the rewarding years. Br. J. Pharmacol., 2006, 147(Suppl 1), S136-S144.
15. Larsen, J.P.; Tandberg, E. Sleep disorders in patients with Parkinson's disease: epidemiology and management. CNS Drugs, 2001, 15(4), 267-275.
16. Arnulf, I.; Konofal, E.; Merino-Andreu, M.; Houeto, J.L.; Mesnage, V.; Welter, M.L.; Lacomblez, L.; Golmard, J.L.; Derenne, J.P.; Agid, Y. Parkinson's disease and sleepiness: an integral part of PD. Neurology, 2002, 58(7), 1019-1024.
17. Tufik, S.; Lindsey, C.J.; Carlini, E.A. Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain? Pharmacology, 1978, 16(2), 98-105.
18. Tufik, S. Increased responsiveness to apomorphine after REM sleep deprivation: supersensitivity of dopamine receptors or increase in dopamine turnover? J. Pharm. Pharmacol., 1981, 33(11), 732-738.
19. Lima, M.M.S.; Andersen, M.L.; Reksidler, A.B.; Silva, A.; Zager, A.; Zanata, S.M.; Vital, M.A.; Tufik, S. Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation. Behav. Brain Res., 2008, 188(2), 406-411.
20. Lima, M.M.S.; Reksidler, A.B.; Vital, M.A. The neurobiology of the substantia nigra pars compacta: from motor to sleep regulation. J. Neural Transm. Suppl., 2009, 73, 135-145.
21. Lima, M.M.S.; Reksidler, A.B.; Vital, M.A.B.F. The dopaminergic dilema: Sleep or wake? implications in Parkinson's disease. Biosci. Hyp., 2008, 1, 9-13.
22. Thiffault, C.; Langston, J.W.; Di Monte, D.A. Increased striatal dopamine turnover following acute administration of rotenone to mice. Brain Res., 2000, 885(2), 283-288.
23. Skalisz, L.L.; Beijamini, V.; Joca, S.L.; Vital, M.A.; da Cunha, C.; Andreatini, R. Evaluation of the face validity of reserpine administration as an animal model of depression--Parkinson's disease association. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2002, 26(5), 879-883.
24. Ghisi, V.; Ramsey, A.J.; Masri, B.; Gainetdinov, R.R.; Caron, M.G.; Salahpour, A. Reduced D2-mediated signaling activity and transsynaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. Cell Signal., 2009, 21(1), 87-94.
25. Nunes, G.P.; Tufik, S.; Nobrega, J.N. Autoradiographic analysis of D1 and D2 dopaminergic receptors in rat brain after paradoxical sleep deprivation. Brain Res. Bull., 1994, 34(5), 453-456.
26. Silva, R.H.; Abilio, V.C.; Takatsu, A.L.; Kameda, S.R.; Grassl, C.; Chehin, A.B.; Medrano, W.A.; Calzavara, M.B.; Registro, S.; Ersen, M.L.; Machado, R.B.; Carvalho, R.C.; Ribeiro Rde, A.; Tufik, S.; Frussa-Filho, R. Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacology, 2004, 46(6), 895-903.
27. Betancur, C.; Lepee-Lorgeoux, I.; Cazillis, M.; Accili, D.; Fuchs, S.; Rostene, W. Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice. Neuropsychopharmacology, 2001, 24(2), 170-182.
28. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the Folin protein reagent. J. Biol. Chem., 1951, 193, 265-275.
29. Petroske, E.; Meredith, G.E.; Callen, S.; Totterdell, S.; Lau, Y.S. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience, 2001, 106(3), 589-601.
30. Poewe, W.; Hogl, B. Parkinson's disease and sleep. Curr. Opin. Neurol., 2000, 13(4), 423-426.
31. Rye, D.B.; Jankovic, J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology, 2002, 58(3), 341-346.
32. Hansard, M.J.; Smith, L.A.; Jackson, M.J.; Cheetham, S.C.; Jenner, P. Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates. J. Pharmacol. Exp. Ther., 2002, 303(3), 952-958.
33. Smith, L.A.; Tel, B.C.; Jackson, M.J.; Hansard, M.J.; Braceras, R.; Bonhomme, C.; Chezaubernard, C.; Del Signore, S.; Rose, S.; Jenner, P. Repeated administration of piribedil induces less dyskinesia than Ldopa in MPTP-treated common marmosets: a behavioural and biochemical investigation. Mov. Disord., 2002, 17(5), 887-901.
34. Hansard, M.J.; Smith, L.A.; Jackson, M.J.; Cheetham, S.C.; Jenner, P. Dopamine reuptake inhibition and failure to evoke dyskinesia in MPTP-treated primates. Eur. J. Pharmacol., 2002, 451(2), 157-160.
35. Decker, M.J.; Rye, D.B. Neonatal intermittent hypoxia impairs dopamine signaling and executive functioning. Sleep Breath., 2002, 6(4), 205-210.
36. Bagetta, G.; De Sarro, G.; Priolo, E.; Nistico, G. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats. Br. J. Pharmacol., 1988, 95(3), 860-866.
37. Maloney, K.J.; Mainville, L.; Jones, B.E. c-Fos expression in dopaminergic and GABAergic neurons of the ventral mesencephalic tegmentum after paradoxical sleep deprivation and recovery. Eur. J. Neurosci., 2002, 15(4), 774-778.
38. Santos, C.A.; Andersen, M.L.; Lima, M.M.; Tufik, S. Gentle handling temporarily increases c-Fos in the substantia nigra pars compacta. Braz. J. Med. Biol. Res., 2008, 41(10), 920-925.
39. Sinha, A.K.; Henriksen, S.; Dement, W.C.; Barchas, J.D. Cat brain amine content during sleep. Am. J. Physiol., 1973, 224(2), 381-383.
40. Basheer, R.; Magner, M.; McCarley, R.W.; Shiromani, P.J. REM sleep deprivation increases the levels of tyrosine hydroxylase and norepinephrine transporter mRNA in the locus coeruleus. Brain Res. Mol. Brain Res., 1998, 57(2), 235-240.
41. Damasceno, F.; Skinner, G.O.; Cordeiro, J.F.; Ferraz, M.R.; Almeida, O.M. Sleep deprivation affects sexual behavior and tyrosine hydroxylase (TH) levels in sexually experienced male rats. Physiol. Behav., 2008, 94(3), 405-411.
42. Majumdar, S.; Mallick, B.N. Increased levels of tyrosine hydroxylase and glutamic acid decarboxylase in locus coeruleus neurons after rapid eye movement sleep deprivation in rats. Neurosci. Lett., 2003, 338(3), 193-196.
43. Pal, D.; Madan, V.; Mallick, B.N. Neural mechanism of rapid eye movement sleep generation: Cessation of locus coeruleus neurons is a necessity. Sheng Li Xue Bao, 2005, 57(4), 401-413.
44. Lima, M.M.S.; Braga Reksidler, A.; Marques Zanata, S.; Bueno Machado, H.; Tufik, S.; Vital, M.A. Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats. Brain Res., 2006, 1101(1), 117-125.
45. Reksidler, A.B.; Lima, M.M.S.; Zanata, S.M.; Machado, H.B.; da Cunha, C.; Reatini, R.; Tufik, S.; Vital, M.A.B.F. The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats. Eur. J. Pharmacol., 2007, 560(2/3), 163-175.
46. Reksidler, A.B.; Lima, M.M.S.; Dombrowski, P.; Ersen, M.L.; Zanata, S.M.; Reatini, R.; Tufik, S.; Vital, M.A.B.F. Repeated intranigral MPTP administration: A new protocol of prolonged locomotor impairment mimicking Parkinson's disease. J. Neurosci. Methods, 2008, 167(2), 268-277.
47. Federici, M.; Natoli, S.; Bernardi, G.; Mercuri, N.B. Dopamine selectively reduces GABA(B) transmission onto dopaminergic neurones by an unconventional presynaptic action. J. Physiol., 2002, 540(Pt 1), 119-128.
48. Salih, F.; Khatami, R.; Steinheimer, S.; Hummel, O.; Kuhn, A.; Grosse, P. Inhibitory and excitatory intracortical circuits across the human sleep-wake cycle using paired-pulse transcranial magnetic stimulation. J. Physiol., 2005, 565(Pt 2), 695-701.
49. Tufik, S. Changes of response to dopaminergic drugs in rats submitted to REM-sleep deprivation. Psychopharmacology (Berl.), 1981, 72(3), 257-260.
50. Barraud, Q.; Lambrecq, V.; Forni, C.; McGuire, S.; Hill, M.; Bioulac, B.; Balzamo, E.; Bezard, E.; Tison, F.; Ghorayeb, I. Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model. Exp. Neurol., 2009, 219(2), 574-582.
51. Laloux, C.; Derambure, P.; Kreisler, A.; Houdayer, E.; Bruezière, S.; Bordet, R.; Destée, A.; Monaca, C. MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations. Exp. Brain Res., 2008, 186, 635-642.